36 evolution "https:" "https:" "https:" "UNIVERSITY OF LUXEMBOURG" Fellowship positions at Center for Drug Evaluation and Research (CDER)
Sort by
Refine Your Search
-
Center for Drug Evaluation and Research (CDER) | Jefferson, Arkansas | United States | about 6 hours ago
, pharmacoepidemiology methods development). You will have learning opportunities that include: Understanding of pharmacovigilance data analysis workflows; Full-stack web-based application development; Integration
-
Center for Drug Evaluation and Research (CDER) | Jefferson, Arkansas | United States | about 6 hours ago
., drug safety, substance use disorders, pharmacovigilance, pharmacoepidemiology methods development). Through this fellowship, you will have opportunities to learn: Understanding of pharmacovigilance
-
Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | about 6 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available immediately with the Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), located in White Oak, Maryland. The Center for Drug Evaluation and Research...
-
Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | about 6 hours ago
disorders, pharmacovigilance, pharmacoepidemiology methods development). Mentor: The mentor for this opportunity is Jason Flint, MBA, PMP, (Jason.Flint@fda.hhs.gov ). If you have questions about the nature
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 6 hours ago
challenge to pediatric drug development especially for the younger children. Some of the challenges in using pediatric drug-device combination products include the delivery of inadequate doses for achieving
-
Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | about 6 hours ago
—an international consensus guideline that promotes transparency and reproducibility in mediation analyses (JAMA 2021;326(11):1045–1056; https://jamanetwork.com/journals/jama/fullarticle/2784353 )—as the
-
Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | about 6 hours ago
(PROs) represent the only quantitative tool available to assess tolerability of oncologic agents under development, providing unique insights into the patient experience of symptomatic adverse events
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 5 hours ago
from FDA-funded scientific research can be used to support PSG development. This project includes the development of knowledge management and research management tools to maintain, monitor, and analyze
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 6 hours ago
drug compounding, including, but not limited to specific bulk drug substances that are used in compounding, advancing FDA's development of the Bulk Lists of substances that can be used in human
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 5 hours ago
developing comprehensive databases to systematically evaluate the current landscape of in vitro data utilization in drug development. This research will contribute to the development of innovative